# Unituxin

NDC: 66302-014
Generic name: DINUTUXIMAB
Labeler / Manufacturer: United Therapeutics Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20150310

FDA application: BLA125516

## Active ingredients

- DINUTUXIMAB: 3.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66302-014"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66302-014
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d66bdf0d-9d65-45de-ae5b-a58617c27492
